Medicinal cannabis is cannabis and cannabinoids that are prescribed by physicians for their patients. Medicinal cannabis is moderate that it helps in chronic pain and muscle spasms.
Market Analysis and Insights: Global Medicinal Cannabis Market
Due to the COVID-19 pandemic, the global Medicinal Cannabis market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Oral Medications accounting for % of the Medicinal Cannabis global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Medicinal Cannabis market size is valued at US$ million in 2021, while the US and Europe Medicinal Cannabis are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Medicinal Cannabis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Medicinal Cannabis include GreenWich, Abbvie, Insys Therapeutics, Bausch Health, Tilray, Corbus Pharmaceuticals, Aphria, Manitoba Harvest and Phytokann, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Medicinal Cannabis Scope and Segment
Medicinal Cannabis market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Medicinal Cannabis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Oral Medications
Topical Medications
Segment by Application
Hospitals
Clinics
Medical Research Centers
By Company
GreenWich
Abbvie
Insys Therapeutics
Bausch Health
Tilray
Corbus Pharmaceuticals
Aphria
Manitoba Harvest
Phytokann
Botanical Genetics
Jinzhou Qiaopai Biotech
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E